<DOC>
	<DOC>NCT01353417</DOC>
	<brief_summary>This non-interventional study intends to collect epidemiological data in patients with stable kidney function after renal transplantation, who receive Tacrolimus Sandoz© according to the approved indication.</brief_summary>
	<brief_title>Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Age: ≥ 18 Post renal transplantation time: ≥ 6 months Stable kidney function ( serum creatinine &lt; 3.0mg/dl; variation &lt; 0.5mg/dl at 2 appointments in minimum distance of 6 days) Stable Tacrolimus Sandoz© dose &gt; 2 weeks before inclusion in this Non Interventional Study (NIS) Written and oral informed consent Wellknown poor compliance with immunosuppressives Acute rejection reaction within the past 3 months or antibodytherapy because of rejection within the past 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Grafting, kidney</keyword>
	<keyword>Transplantation, kidney</keyword>
</DOC>